Olfson, M., McClellan, C., Zuvekas, S. H., Wall, M., & Blanco, C. (2025). Use of Telemental Health Care by Children and Adolescents in the United States. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20240193

Aaronson, S. T., van der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Suppes, T., & Sackeim, H. A. (2025). Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial. American Journal of Psychiatry, 182(1), 104–113. https://doi.org/10.1176/appi.ajp.20231063

Perlman, G., Wengler, K., Moeller, S. J., Kotov, R., Klein, D. N., Weinstein, J. J., Horga, G., & Abi-Dargham, A. (2024). Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women. American Journal of Psychiatry, 181(11), 997–1005. https://doi.org/10.1176/appi.ajp.20220819

Imperio, C. G., Levin, F. R., & Martinez, D. (2024). The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists. American Journal of Psychiatry, 181(11), 958–972. https://doi.org/10.1176/appi.ajp.20231023

Bommersbach, T. J., Olfson, M., & Rhee, T. G. (2024). National Trends in Emergency Department Visits for Suicide Attempts and Intentional Self-Harm. American Journal of Psychiatry, 181(8), 741–752. https://doi.org/10.1176/appi.ajp.20230397

Williams, A. R., Mauro, C. M., Huber, B., Chiodo, L., Crystal, S., Samples, H., & Olfson, M. (2024). Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement. American Journal of Psychiatry, 181(5), 457–459. https://doi.org/10.1176/appi.ajp.20230808

van der Pluijm, M., Wengler, K., Reijers, P. N., Cassidy, C. M., Tjong Tjin Joe, K., de Peuter, O. R., Horga, G., Booij, J., de Haan, L., & van de Giessen, E. (2024). Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia. American Journal of Psychiatry, 181(6), 512–519. https://doi.org/10.1176/appi.ajp.20220780

Joseph, V. A., Martínez-Alés, G., Olfson, M., Shaman, J., Gould, M. S., Gimbrone, C., & Keyes, K. M. (2023). Trends in Suicide Among Black Women in the United States, 1999–2020. American Journal of Psychiatry, 180(12), 914–917. https://doi.org/10.1176/appi.ajp.20230254

Livne, O., Malte, C. A., Olfson, M., Wall, M. M., Keyes, K. M., Maynard, C., Gradus, J. L., Saxon, A. J., Martins, S. S., Keyhani, S., McDowell, Y., Fink, D. S., Mannes, Z. L., Gutkind, S., & Hasin, D. S. (2024). Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019. American Journal of Psychiatry, 181(2), 144–152. https://doi.org/10.1176/appi.ajp.20230168

Breslow, A. S., Simkovic, S., Franz, P. J., Cavic, E., Liu, Q., Ramsey, N., Alpert, J. E., Cook, B. L., & Gabbay, V. (2023). Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care Workers. American Journal of Psychiatry, 180(12), 896–905. https://doi.org/10.1176/appi.ajp.20220180

Docherty, A. R., Mullins, N., Ashley-Koch, A. E., Qin, X., Coleman, J. R. I., Shabalin, A., Kang, J., Murnyak, B., Wendt, F., Adams, M., Campos, A. I., DiBlasi, E., Fullerton, J. M., Kranzler, H. R., Bakian, A. V., Monson, E. T., Rentería, M. E., Walss-Bass, C., … Andreassen, O. A. (2023). GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors. American Journal of Psychiatry, 180(10), 723–738. https://doi.org/10.1176/appi.ajp.21121266

Olfson, M., Waidmann, T., King, M., Pancini, V., & Schoenbaum, M. (2023). Opioid Prescribing and Suicide Risk in the United States. American Journal of Psychiatry, 180(6), 418–425. https://doi.org/10.1176/appi.ajp.22020102

Williams, A. R., Mauro, C. M., Feng, T., Wilson, A., Cruz, A., Olfson, M., Crystal, S., Samples, H., & Chiodo, L. (2023). Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention. American Journal of Psychiatry, 180(6), 454–457. https://doi.org/10.1176/appi.ajp.20220456

Brandt, L., Hu, M.-C., Liu, Y., Castillo, F., Odom, G. J., Balise, R. R., Feaster, D. J., Nunes, E. V., & Luo, S. X. (2023). Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. American Journal of Psychiatry, 180(5), 386–394. https://doi.org/10.1176/appi.ajp.20220312

Veenstra-VanderWeele, J., O’Reilly, K. C., Dennis, M. Y., Uribe-Salazar, J. M., & Amaral, D. G. (2023). Translational Neuroscience Approaches to Understanding Autism. American Journal of Psychiatry, 180(4), 265–276. https://doi.org/10.1176/appi.ajp.20230153

Russman Block, S., Norman, L. J., Zhang, X., Mannella, K. A., Yang, H., Angstadt, M., Abelson, J. L., Himle, J. A., Taylor, S. F., & Fitzgerald, K. D. (2023). Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial. American Journal of Psychiatry, 180(1), 89–99. https://doi.org/10.1176/appi.ajp.21111173

Hasin, D. S., Shmulewitz, D., Stohl, M., Greenstein, E., Aharonovich, E., Petronis, K. R., Von Korff, M., Datta, S., Sonty, N., Ross, S., Inturrisi, C., Weinberger, M. L., Scodes, J., & Wall, M. M. (2022). Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain. American Journal of Psychiatry, 179(10), 715–725. https://doi.org/10.1176/appi.ajp.21070721

Hasin, D. S., Saxon, A. J., Malte, C., Olfson, M., Keyes, K. M., Gradus, J. L., Cerdá, M., Maynard, C. C., Keyhani, S., Martins, S. S., Fink, D. S., Livne, O., Mannes, Z., & Wall, M. M. (2022). Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019. American Journal of Psychiatry, 179(10), 748–757. https://doi.org/10.1176/appi.ajp.22010034

Chand, G. B., Singhal, P., Dwyer, D. B., Wen, J., Erus, G., Doshi, J., Srinivasan, D., Mamourian, E., Varol, E., Sotiras, A., Hwang, G., Dazzan, P., Kahn, R. S., Schnack, H. G., Zanetti, M. V., Meisenzahl, E., Busatto, G. F., Crespo-Facorro, B., Pantelis, C., … Davatzikos, C. (2022). Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population. American Journal of Psychiatry, 179(9), 650–660. https://doi.org/10.1176/appi.ajp.21070686

Hankerson, S. H., Moise, N., Wilson, D., Waller, B. Y., Arnold, K. T., Duarte, C., Lugo-Candelas, C., Weissman, M. M., Wainberg, M., Yehuda, R., & Shim, R. (2022). The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression. American Journal of Psychiatry, 179(6), 434–440. https://doi.org/10.1176/appi.ajp.21101000

Markowitz, J. C., Wright, J. H., Peeters, F., Thase, M. E., Kocsis, J. H., & Sudak, D. M. (2022). The Neglected Role of Psychotherapy for Treatment-Resistant Depression. American Journal of Psychiatry, 179(2), 90–93. https://doi.org/10.1176/appi.ajp.2021.21050535

Tadmon, D., & Olfson, M. (2022). Trends in Outpatient Psychotherapy Provision by U.S. Psychiatrists: 1996–2016. American Journal of Psychiatry, 179(2), 110–121. https://doi.org/10.1176/appi.ajp.2021.21040338

Haney, M. (2022). Cannabis Use and the Endocannabinoid System: A Clinical Perspective. American Journal of Psychiatry, 179(1), 21–25. https://doi.org/10.1176/appi.ajp.2021.21111138

Livne, O., Shmulewitz, D., Sarvet, A. L., Wall, M. M., & Hasin, D. S. (2022). Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013. American Journal of Psychiatry, 179(1), 36–45. https://doi.org/10.1176/appi.ajp.2021.21010073

Browne, K. C., Stohl, M., Bohnert, K. M., Saxon, A. J., Fink, D. S., Olfson, M., Cerda, M., Sherman, S., Gradus, J. L., Martins, S. S., & Hasin, D. S. (2022). Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). American Journal of Psychiatry, 179(1), 26–35. https://doi.org/10.1176/appi.ajp.2021.20081202